The Regents of the University of Minnesota will receive $4.67 million under a three-year Project Grant from the National Institute on Aging within the Department of Health and Human Services. The grant funds research under the Aging Research program (CFDA 93.866) to characterize neuroplastic changes and their relationship to emerging motor and cognitive deficits in individuals with isolated rapid eye movement sleep behavior disorder (IRBD). Over the period of performance from August 2022 through...
The National Institute on Aging (NIA) awarded a $2,210,409 Project Grant (CFDA 93.866 - Aging Research) to The Trustees of the University of Pennsylvania to examine ways to better align the financial incentives between the Medicaid and Medicare programs for nursing home care provided to residents with Alzheimer's disease and related dementias (AD/ADRD). The project aims to address the conflicts in the current payment structures that contribute to fragmented, low-quality care and high costs for...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a 3-year, $199,263 research project titled "PROJECT GLORY: GOOD LIFE IN MEMORY CARE". The project aims to gain a deeper understanding of how to promote quality of life for nursing home residents with Alzheimer's disease and related dementias. Key activities include: 1) collecting first-hand experiences from residents, families, and staff on care practices and quality of life; 2)...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This $12,868,304 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a comprehensive, prospective study examining the relationship between incarceration and health outcomes, age-related conditions, and risk factors for Alzheimer's disease and related dementias (ADRD). The 5-year study will leverage an existing 28-year longitudinal dataset from the Northwestern Juvenile Project, interviewing 1,492 participants aged 39-49 to assess physical and...
This three-year, $6.5 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research under the Aging Research program (CFDA 93.866). The grantee, the Regents of the University of Minnesota, will assess the acute and long-term impacts of SARS-CoV-2 infection on cognitive function and neuropathology in aging and Alzheimer's disease. Specifically, the University of Minnesota researchers will test hypotheses about how the...
This $1,933,556 Project Grant awarded by the National Institute on Aging (NIA) under its Aging Research program (CFDA 93.866) will support research to assess the impact of hospital-based health information technology (hospital-HIT) on healthcare quality and equity for patients with Alzheimer's disease and related dementias (ADRD). The primary awardee, the University of Maryland, College Park, will conduct a ten-year longitudinal study to evaluate how hospital-HIT systems that promote care...
The University of Pennsylvania received a $2,278,636 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to characterize and evaluate different nursing home clinician care models and their impact on health outcomes and costs for nursing home residents with Alzheimer's disease and related dementias (ADRD). The key products and services to be delivered under this 3-year award include: Surveying a nationally representative sample of nursing home clinicians,...
This federal Project Grant award, valued at $107,948.00, was provided by the National Institute on Aging under the Aging Research program (CFDA 93.866) to the Regents of the University of Minnesota. The primary objective of this research project is to investigate the role of regulatory T cells (Tregs) in Alzheimer's disease (AD) progression. Specifically, the research aims to characterize the types and spatial localization of Tregs in aging wild-type and AD mouse brains (Aim 1), and to determine...
The National Institute on Aging (NIA) awarded Brown University a $608,731 project grant under the Aging Research Federal Grant Program (CFDA 93.866) to study the impact of Medicare and Medicaid financial policies on post-acute and long-term care utilization and outcomes for persons living with Alzheimer's disease and related dementias (ADRD). The project, running from September 1, 2024 to May 31, 2029, will leverage Medicare claims and clinical assessment data to analyze how changes to...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $680,931 to the Regents of the University of Minnesota to conduct a comprehensive analysis of the prevalence, care needs, and organizational barriers for nursing home residents with serious mental illness (SMI), with and without Alzheimer's disease and related dementias (AD/ADRD), across racial and ethnic groups. The 5-year project will: 1) assess longitudinal patterns of SMI, AD/ADRD, and SMI with comorbid AD/ADRD in nursing homes; 2) estimate quality of life and quality of care outcomes for those with SMI with and without AD/ADRD; and 3) perform qualitative case studies, including facility observations and interviews, to identify modifiable organizational factors that can facilitate care for these vulnerable populations. This research aims to address critical gaps in the evidence base for high-quality, equitable nursing home care for individuals with SMI, with and without comorbid dementia, particularly among Black, Indigenous, and people of color.